Genetic profile of patients with atypical hemolytic uremic syndrome
- Авторлар: Ivanova E.S.1, Stolyarevich E.S.1,2, Kotenko O.N.1, Vinogradov V.E.1, Artyukhina L.Y.1, Frolova N.F.1, Shatalov P.A.3, Ilyinsky V.V.4
-
Мекемелер:
- Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology “City Clinical Hospital № 52” of the Moscow Healthcare Department
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry
- National Medical Research Center for Radiology
- ООО Genotech LLC
- Шығарылым: Том 14, № 2 (2022)
- Беттер: 25-32
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/276108
- DOI: https://doi.org/10.18565/nephrology.2022.2.25-32
- ID: 276108
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
Ekaterina Ivanova
Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology “City Clinical Hospital № 52” of the Moscow Healthcare Department
Email: katerineiv@mail.ru
Cand. Sci. (Med.), Nephrologist, Nephrology Department № 1 Moscow, Russia
Ekaterina Stolyarevich
Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology “City Clinical Hospital № 52” of the Moscow Healthcare Department; A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Email: stolyarevich@yandex.ru
Dr. Sci. (Med.), Professor at the Department of Nephrology, FPGE , A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Morbid Anatomist at the pathologist of the Department of Pathologic Anatomy, City Clinical Hospital № 52 of the Moscow Healthcare Department Moscow, Russia
Oleg Kotenko
Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology “City Clinical Hospital № 52” of the Moscow Healthcare Department
Email: olkotenko@yandex.ru
Cand. Sci. (Med.), Chief Freelance Expert in Nephrology of the Moscow Healthcare Department, Head of the Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology Moscow, Russia
Vladimir Vinogradov
Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology “City Clinical Hospital № 52” of the Moscow Healthcare Department
Email: vino-gradoff@yandex.ru
Head of the Consultative and Diagnostic Nephrology Department Moscow, Russia
Lyudmila Artyukhina
Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology “City Clinical Hospital № 52” of the Moscow Healthcare Department
Email: arlyu-1404@yandex.ru
Cand.Sci. (Med.), Head of the Nephrology Department № 1 Moscow, Russia
Nadiya Frolova
Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology “City Clinical Hospital № 52” of the Moscow Healthcare Department
Email: nadiya.frolova@yandex.ru
Cand. Sci.(Med.), Deputy Chief Physician for Nephrological Care Moscow, Russia
Petr Shatalov
National Medical Research Center for RadiologyCand. Sci. (Med.), Head ofthe Molecular Genetic Service Obninsk, Russia
Valery Ilyinsky
ООО Genotech LLCGeneral Director Moscow, Russia
Әдебиет тізімі
- Nester C.M., Barbour T., de Cordoba S.R., et al. Atypical aHUS: State of the art. Mol. Immunol. 2015;67:31-42.
- Bu F., Zhang Y., Wang K., et al. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome. J. Am. Soc. Nephrol. 2018;29(12):2809-19. doi: 10.1681/ASN.2018070759.
- Legendre C.M., Licht C., Muus P., et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2013;368:2169-81.
- Rathbone J., Kaltenthaler E., Richards A., et al. A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS). BMJ. Open. 2013;3:e003573.
- Goodship T.H., Cook H.T., Fakhouri F., et al. Conference Participants: Atypical hemolytic uremic syndrome and C3 glomerulopathy: Conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conference. Kidney Int. 2017;91:539-51.
- Kavanagh D., Goodship T.H., Richards A. Atypical hemolytic uremic syndrome. Semin. Nephrol. 2013;33:508-30.
- Jokiranta T.S: HUS and atypical HUS. Blood. 2017;129:2847-56.
- Durey M.A., Sinha A., Togarsimalemath S.K., Bagga A. Anti-complement-factor H-associated glomerulopathies. Nat. Rev. Nephrol. 2016;12:563-78.
- Noris M., Caprioli.J, Bresin E., et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin. J. Am. Soc. Nephrol. 2010;5(10):1844-59. doi: 10.2215/CJN.02210310.
- Lek M., Karczewski K.J., Minikel E.V., et al. Exome Aggregation Consortium: Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285-91.
- Marinozzi M.C., Vergoz L., Rybkine T., et al.Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign? J. Am. Soc. Nephrol. 2014;25:2053-65.
- Merinero H.M., Garcia S.P, Garcia-Fernândez J., et al.Complete functional characterization of disease-associated genetic variants in the complement factor H gene. Kidney Int. 2018;93:470-81.
- Fakhouri F., Zuber J., Fremeaux-Bacchi V., Loirat C. Haemolytic uraemic syndrome. Lancet. 2017;217:681-96.
- Osborne A.J., et al. Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy. J. Immunol. 2018;200:2464-78.
- Merle N.S., Church S.E., Fremeaux-Bacchi V., Roumenina L.T.Complement system Part I - molecular mechanisms of activation and regulation. Front. Immunol. 2015;6:262.
- Fremeaux-Bacchi V., Fakhouri F., Garnier A., et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin. J. Am. Soc Nephrol. 2013;8(4):554-62. doi: 10.2215/CJN.04760512.
- Maga T.K., Nishimura C.J., Weaver A.E., et al. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum. Mutat. 2010;31(6):E1445-60. doi: 10.1002/humu.21256.
- Fujisawa M., Kato H., Yoshida Y., et al. Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome [published correction appears in Clin. Exp. Nephrol. 2019 Apr 23]. Clin. Exp. Nephrol. 2018;22(5):1088-099. doi: 10.1007/s10157-018-1549-3.
- Fakhouri F., Roumenina L., Provot F., et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J. Am. Soc. Nephrol 2010;21(5):859-67. doi: 10.1681/ASN.2009070706.
- Zipfel P.F., Wiech T., Stea E.D., Skerka C. CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. J. Am. Soc. Nephrol. 2020;31(2):241-56. doi: 10.1681/ASN.2019050515.
- Nozawa A., Ozeki M., Hori T., et al. A Heterozygous CFHR3-CFHR1 Gene Deletion in a Pediatric Patient With Transplant-associated Thrombotic Microangiopathy Who was Treated With Eculizumab. J. Pediatr. Hematol. Oncol. 2018;40(8):e544-46. https://doi.org/10.1097/MPH.0000000000000986
- Zipfel P.F., et al. CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. J. Am. Society Nephrol.: JASN 2020;31,2:241-56. doi: 10.1681/ASN.2019050515.
- Kandari S., Chakurkar V., Gaikwad S., et al. High prevalence of CFHR deletions in Indian women with pregnancy-associated hemolytic uremic syndrome. Nephrol. (Carlton). 2022;27(3):231-7. doi: 10.1111/nep.14004.
- Formeck C., Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr. Nephrol. 2019;34(8):1337-48. doi: 10.1007/s00467-018-4039-7.
- Noris M., Remuzzi G. Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation. Curr. Opin Nephrol. Hypertens. 2013;22:704-12.
- Noris M., Bresin E., Mele C., Remuzzi G. Genetic Atypical Hemolytic-Uremic Syndrome. 2007 Nov 16 [updated 2021 Sep 23]. In: M.P. Adam, H.H. Ardinger, R.A. Pagon, et al. ed. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. PMID: 20301541. of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. J. Am. Society Nephrol.: JASN 2020;31,2:241-56. doi: 10.1681/ASN.2019050515.
Қосымша файлдар
![](/img/style/loading.gif)